
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

